Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
Alhadj Ali M, Liu YF, Arif S, Tatovic D, Shariff H, Gibson VB, Yusuf N, Baptista R, Eichmann M, Petrov N, Heck S, Yang JHM, Tree TIM, Pujol-Autonell I, Yeo L, Baumard L, Stenson R, Howell A, Clark A, Boult Z, Powrie J, Adams L, Wong FS, Luzio S, Dunseath G, Green K, O'Keefe A, Bayly G, Thorogood N, Andrews R, Leech N, Joseph F, Nair S, Seal S, Cheung H, Beam C, Hills R, Peakman M, Dayan CM. Alhadj Ali M, et al. Among authors: green k. Sci Transl Med. 2017 Aug 9;9(402):eaaf7779. doi: 10.1126/scitranslmed.aaf7779. Sci Transl Med. 2017. PMID: 28794283 Clinical Trial.
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, Wong FS, Dayan CM, Peakman M. Thrower SL, et al. Among authors: green km. Clin Exp Immunol. 2009 Feb;155(2):156-65. doi: 10.1111/j.1365-2249.2008.03814.x. Epub 2008 Nov 20. Clin Exp Immunol. 2009. PMID: 19040615 Free PMC article. Clinical Trial.
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Barnard-Kelly K, Sutton CJ, Elliott RA, Taxiarchi VP, Gkountouras G, Burns M, Mubita W, Kanumilli N, Camm M, Thabit H, Wilmot EG; FLASH-UK Trial Study Group. Leelarathna L, et al. N Engl J Med. 2022 Oct 20;387(16):1477-1487. doi: 10.1056/NEJMoa2205650. Epub 2022 Oct 5. N Engl J Med. 2022. PMID: 36198143 Clinical Trial.
APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.
Tran KM, Kwang NE, Butler CA, Gomez-Arboledas A, Kawauchi S, Mar C, Chao D, Barahona RA, Da Cunha C, Tsourmas KI, Shi Z, Wang S, Collins S, Walker A, Shi KX, Alcantara JA, Neumann J, Duong DM, Seyfried NT, Tenner AJ, LaFerla FM, Hohsfield LA, Swarup V, MacGregor GR, Green KN. Tran KM, et al. Among authors: green kn. Mol Neurodegener. 2025 Jan 22;20(1):9. doi: 10.1186/s13024-024-00793-x. Mol Neurodegener. 2025. PMID: 39844286
Meeting report - Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseases.
Waschke J, Amagai M, Becker C, Delmar M, Duru F, Garrod DR, Gerull B, Green KJ, Hertl M, Kowalczyk AP, Niessen CM, Nusrat A, Schinner C, Schlegel N, Sivasankar S, Vielmuth F, Spindler V. Waschke J, et al. Among authors: green kj. J Cell Sci. 2025 Jan 15;138(2):JCS263796. doi: 10.1242/jcs.263796. Epub 2025 Jan 22. J Cell Sci. 2025. PMID: 39838950
Quantifying capacity of otolaryngology-head and neck surgery in Zimbabwe.
Green KJ, Eyassu DG, Jain A, Arya P, Candelo E, Douse DM, Matinhira NN, Chidziva C, Wiedermann JP. Green KJ, et al. Laryngoscope Investig Otolaryngol. 2025 Jan 7;10(1):e70062. doi: 10.1002/lio2.70062. eCollection 2025 Feb. Laryngoscope Investig Otolaryngol. 2025. PMID: 39780860 Free PMC article.
2,659 results